HbA1c is a blood test that measures a person’s average blood sugar level over approximately the past two to three months. It is commonly used to screen for prediabetes and diabetes, diagnose these conditions, and monitor how well blood sugar is controlled in people who already have diabetes.
Unlike a standard blood glucose test, which measures the amount of sugar in the blood at a particular moment, HbA1c provides a longer-term picture of blood sugar exposure. This makes it useful for identifying persistent elevations that might not be apparent from a single reading.
For most nonpregnant adults, an HbA1c below 5.7% is considered normal, 5.7% to 6.4% indicates prediabetes, and 6.5% or higher is in the diabetes range. These thresholds help guide medical decisions, but a test result must be interpreted in the context of a person’s health, symptoms, and other laboratory findings.
What is HbA1c?
HbA1c stands for glycated hemoglobin, a form of hemoglobin that has glucose attached to it. Hemoglobin is the protein inside red blood cells that carries oxygen from the lungs to tissues throughout the body.
When glucose circulates in the bloodstream, some of it naturally attaches to hemoglobin. This process, called glycation, occurs continuously and does not require an enzyme to initiate it. The higher the blood glucose level, the more glucose tends to attach to hemoglobin over time.
Red blood cells typically circulate for about 120 days before being removed from the bloodstream. Because glucose accumulates on hemoglobin during the life of these cells, measuring HbA1c provides an estimate of how much glucose the blood has been exposed to over the preceding several months.
The result is reported as a percentage. A higher percentage means that a greater proportion of hemoglobin is glycated, generally indicating higher average blood glucose.
HbA1c is not a direct measurement of glucose, nor does it represent an exact average of every blood sugar reading over the previous 90 days. More recent blood glucose levels tend to have a greater influence on the result because the blood contains red blood cells of different ages.
What is the normal HbA1c range?
For most nonpregnant adults, HbA1c results are interpreted using three main categories: normal, prediabetes, and diabetes.
| HbA1c result | Interpretation |
|---|---|
| Below 5.7% | Normal range |
| 5.7% to 6.4% | Prediabetes range |
| 6.5% or higher | Diabetes range |
These thresholds are used in the United States to help identify abnormal glucose regulation. They apply to standard diagnostic testing in appropriate clinical circumstances, rather than every situation in which HbA1c is measured.
A result below 5.7% generally indicates that average blood glucose has been within the expected range for someone without diabetes. However, a normal result does not rule out every form of abnormal glucose regulation. Someone with symptoms or significant risk factors may need additional testing.
An HbA1c of 5.7% to 6.4% indicates prediabetes, a condition in which blood glucose is higher than normal but below the threshold for diabetes. It signals an increased risk of developing type 2 diabetes and related health problems, although progression is not inevitable.
An HbA1c of 6.5% or higher falls within the diabetes range. In someone without clear symptoms of diabetes, this finding generally requires confirmation with a repeat HbA1c test or another appropriate diagnostic test.
The boundaries are useful clinical tools, not sharp biological divisions. A result of 6.4% and a result of 6.5% are very close, even though they fall into different diagnostic categories. Small differences can reflect ordinary biological or laboratory variation, so borderline results should be interpreted carefully.
What do HbA1c results mean?
The meaning of an HbA1c result depends on whether the test is being used to screen for diabetes, confirm a diagnosis, or monitor an established condition.
A result below 5.7%
An HbA1c below 5.7% is generally considered normal. It suggests that blood glucose has not been persistently elevated enough to meet the laboratory criteria for prediabetes or diabetes.
A normal result does not guarantee that blood glucose is always normal. Glucose can rise temporarily after meals, during illness, or in response to certain medications. Some people may also have abnormal fasting glucose or elevated blood sugar after a glucose challenge despite having an HbA1c below 5.7%.
For people with symptoms such as excessive thirst, frequent urination, unexplained weight loss, or blurred vision, further evaluation may be appropriate even when HbA1c is normal.
A result of 5.7% to 6.4%
This range indicates prediabetes. The body may be becoming less responsive to insulin, may not be producing enough insulin to maintain normal glucose levels, or may be experiencing a combination of these changes.
Prediabetes does not mean that type 2 diabetes is certain to develop. Blood glucose regulation can improve, particularly when contributing factors such as physical inactivity, excess body weight, or certain dietary patterns are addressed. Some people may also benefit from medication, depending on their individual risk.
Because prediabetes often causes no noticeable symptoms, testing can reveal changes that would otherwise go undetected. Identifying these changes creates an opportunity to reduce the likelihood of progression to diabetes and to address other cardiovascular risk factors.
A result of 6.5% or higher
An HbA1c of 6.5% or higher is in the diabetes range. This indicates that glucose exposure has generally been high enough to meet an established diagnostic threshold, provided the test is reliable and the result is interpreted appropriately.
In a person without unequivocal symptoms or a hyperglycemic emergency, a second abnormal result is generally needed to confirm the diagnosis. This may come from a repeat HbA1c test or a different diagnostic test, such as fasting plasma glucose.
The diagnosis does not, by itself, identify the type of diabetes. Type 1 diabetes, type 2 diabetes, and certain other forms of diabetes have different underlying causes and treatment needs. A clinician considers age, symptoms, medical history, medication use, and other findings to determine the most likely explanation.
A higher HbA1c generally indicates greater average glucose exposure, but the number alone cannot establish how long someone has had diabetes, whether complications are already present, or which treatment is best.
How does blood sugar affect HbA1c?
The relationship between blood glucose and HbA1c begins with the body’s regulation of glucose, the main sugar circulating in the bloodstream.
After a meal, carbohydrates are broken down into glucose, which enters the blood. The pancreas releases insulin, a hormone that helps many cells take up glucose and helps the body store or use it. Between meals, the liver releases glucose to supply tissues with energy.
In diabetes, this regulatory system does not work effectively enough to maintain normal blood glucose. In type 1 diabetes, the immune system destroys the pancreatic cells responsible for producing insulin, resulting in an insulin deficiency. In type 2 diabetes, the body’s tissues become less responsive to insulin, a condition known as insulin resistance, and the pancreas may eventually be unable to produce enough insulin to compensate.
When glucose remains elevated, more of it attaches to hemoglobin inside red blood cells. This raises the proportion of glycated hemoglobin and therefore increases the HbA1c result.
Persistently high blood glucose can damage blood vessels and other tissues over time. Diabetes is associated with an increased risk of kidney disease, nerve damage, eye disease, cardiovascular disease, and other complications. Keeping glucose levels within an appropriate target range can reduce the risk of many of these problems.
HbA1c is useful because it reflects this longer-term exposure rather than relying on isolated blood sugar measurements. However, it does not show the full pattern of glucose fluctuations. Two people with the same HbA1c may experience different degrees of high and low blood sugar during the day.
How is the HbA1c test performed?
The HbA1c test is usually performed using a blood sample collected from a vein in the arm. In some settings, a finger-stick sample can be analyzed using a point-of-care device.
Unlike a fasting blood glucose test, an HbA1c test generally does not require fasting. Food eaten shortly before the test has little immediate effect on the result because the measurement reflects glucose attachment to hemoglobin over a much longer period.
The laboratory measures the proportion of glycated hemoglobin relative to total hemoglobin and reports the result as a percentage. Some laboratories also report an estimated average glucose value, which expresses the HbA1c result in units similar to those used by home glucose meters.
Laboratory methods matter. Diagnostic testing should use an appropriate, standardized method, and clinicians must consider whether conditions affecting red blood cells could make the result unreliable.
An HbA1c test is often ordered during routine medical care for people with diabetes risk factors, symptoms of high blood sugar, or a known history of abnormal glucose regulation. It may also be part of regular monitoring for someone already receiving diabetes treatment.
What is the difference between HbA1c and blood glucose testing?
HbA1c and blood glucose tests measure different aspects of glucose regulation.
A blood glucose test measures the amount of glucose present in a blood sample at the time it is collected. A fasting blood glucose test is taken after a period without food, while a random blood glucose test can be taken at any time. An oral glucose tolerance test measures how the body handles a defined amount of glucose over a specified period.
HbA1c, by contrast, estimates longer-term glucose exposure through the proportion of hemoglobin that has become glycated.
| Test | What it measures | Common use |
|---|---|---|
| HbA1c | Longer-term glucose exposure | Diagnosing and monitoring diabetes |
| Fasting blood glucose | Blood glucose after fasting | Screening for and diagnosing diabetes |
| Random blood glucose | Blood glucose at a particular moment | Evaluating suspected high blood sugar, especially with symptoms |
| Oral glucose tolerance test | The body’s response to a glucose drink | Diagnosing diabetes and certain forms of abnormal glucose regulation |
For nonpregnant adults, fasting plasma glucose levels of 99 milligrams per deciliter (mg/dL) or lower are generally considered normal. Levels of 100 to 125 mg/dL fall within the prediabetes range, and levels of 126 mg/dL or higher fall within the diabetes range.
A two-hour plasma glucose result of 140 to 199 mg/dL during a standard oral glucose tolerance test indicates prediabetes, while a result of 200 mg/dL or higher is in the diabetes range. A random plasma glucose level of 200 mg/dL or higher can also support a diabetes diagnosis when accompanied by classic symptoms of high blood sugar or a hyperglycemic crisis.
These tests are complementary rather than interchangeable. A person may have a normal HbA1c but an elevated fasting glucose, or an HbA1c in the prediabetes range with a fasting glucose that remains normal. When results disagree, additional testing and consideration of factors affecting HbA1c may be necessary.
What is estimated average glucose?
Estimated average glucose, often abbreviated eAG, translates an HbA1c result into an approximate average blood glucose level expressed in mg/dL. This can make the result easier to understand for people who are accustomed to checking blood sugar with a home meter.
For example, an HbA1c of 7.0% corresponds to an estimated average glucose of approximately 154 mg/dL. An HbA1c of 6.0% corresponds to approximately 126 mg/dL, while 8.0% corresponds to approximately 183 mg/dL.
These estimates are based on a statistical relationship between HbA1c and average glucose. They are not exact predictions of an individual’s daily blood sugar readings.
A person’s glucose may rise substantially after meals and fall between meals or during physical activity. HbA1c averages these changes into a single measure, so it cannot show how often glucose becomes unusually high or dangerously low. Continuous glucose monitoring or structured blood glucose testing can provide additional information when glucose patterns matter for treatment decisions.
What is a normal HbA1c for someone with diabetes?
The diagnostic threshold for diabetes is not the same as the treatment target for someone who already has the condition.
For many nonpregnant adults with diabetes, an HbA1c below 7% is a common treatment goal. However, the appropriate target varies with age, duration of diabetes, other medical conditions, life expectancy, risk of hypoglycemia, treatment burden, and personal preferences.
Some people may benefit from a lower target if it can be achieved safely. Others may need a less stringent goal, particularly when treatment creates a substantial risk of dangerously low blood sugar or when other health concerns take priority.
An HbA1c of 7.5%, for example, does not have the same meaning in every person. For someone whose established target is below 7%, it may indicate that treatment needs reassessment. For another person with substantial health complications or a high risk of hypoglycemia, the same result may be closer to an appropriate individualized goal.
Treatment decisions should not be based on HbA1c alone. Symptoms, home glucose readings, continuous glucose monitoring data, medication effects, and the frequency of low blood sugar episodes all help determine whether a treatment plan is working safely.
What can cause an inaccurate HbA1c result?
HbA1c is a reliable test for many people, but it depends on the normal lifespan and composition of red blood cells. Conditions that alter red blood cell turnover or hemoglobin can make the result differ from what would be expected based on actual blood glucose.
Anemia and iron deficiency can affect HbA1c interpretation. Iron-deficiency anemia may raise HbA1c in some circumstances, even without a corresponding increase in blood glucose. Other forms of anemia can lower or otherwise distort the result, depending on their cause and how they affect red blood cell survival.
Recent blood loss or blood transfusion can also interfere with interpretation. Significant blood loss and the subsequent production of new red blood cells may lower HbA1c, while a transfusion can introduce red blood cells with a different glycation history. The direction and size of the effect depend on the circumstances.
Hemoglobin variants, including sickle cell trait and other inherited differences in hemoglobin, may interfere with certain laboratory methods. Some variants also affect red blood cell lifespan. The impact depends on the specific variant and the method used to measure HbA1c.
Pregnancy changes red blood cell turnover and glucose regulation, making HbA1c less suitable for some aspects of diabetes screening and diagnosis during pregnancy. Gestational diabetes is generally assessed using glucose-based testing rather than relying on HbA1c alone.
Kidney disease and other chronic conditions may also complicate interpretation, particularly when they cause anemia, alter red blood cell survival, or require treatments that affect blood cell production.
Some medications and medical treatments can influence HbA1c indirectly by changing red blood cell turnover or blood glucose. When an HbA1c result does not match home glucose readings, symptoms, or other laboratory findings, a clinician may investigate these possibilities and use alternative tests.
How often should HbA1c be tested?
The appropriate testing interval depends on a person’s health status and the purpose of the test.
For adults with normal results and no major risk factors, repeat screening may be appropriate about every three years, although the interval can be shorter when risk is elevated. People with prediabetes are generally advised to have their glucose status checked at least annually, with the timing adjusted to their individual circumstances.
For people with diabetes whose treatment and glucose levels are stable and who are meeting their goals, HbA1c is commonly checked about twice a year. Testing approximately every three months may be appropriate when treatment changes, glucose targets are not being met, or additional information is needed to guide care.
Testing too frequently may not provide much useful information because HbA1c changes gradually as new red blood cells replace older ones. A meaningful change in glucose control may take several weeks to become fully reflected in the result.
These intervals are general guidelines rather than fixed rules. Symptoms, pregnancy, changes in medication, acute illness, and other clinical circumstances can warrant a different testing schedule.
Can HbA1c levels be lowered?
When HbA1c is elevated because of persistently high blood glucose, lowering average glucose can reduce the result over time. The most appropriate approach depends on whether a person has prediabetes, type 1 diabetes, type 2 diabetes, or another condition affecting glucose regulation.
Regular physical activity can improve insulin sensitivity, allowing muscles to use glucose more effectively. For people with excess body weight, sustained weight loss may improve glucose regulation and reduce the risk of developing type 2 diabetes. Eating patterns that emphasize vegetables, legumes, whole grains, fiber-rich foods, and appropriate portions of carbohydrate-containing foods can also support blood glucose management.
Adequate sleep, management of contributing health conditions, and attention to medications that raise blood glucose may be important as well. These measures can be beneficial, but they do not replace insulin or other necessary medical treatment.
People with type 1 diabetes require insulin because their bodies cannot produce enough of it. People with type 2 diabetes may need a combination of lifestyle measures and medications, depending on how their condition responds over time. Medication choices should account for effectiveness, side effects, other medical conditions, and the risk of hypoglycemia.
An elevated HbA1c should not be treated as a number to lower at any cost. Excessively aggressive treatment can cause dangerously low blood sugar, particularly in people using insulin or certain glucose-lowering medications. The goal is to improve glucose control safely and sustainably.
Because HbA1c reflects glucose exposure over several months, changes in treatment or daily habits will not usually produce their full effect immediately. Follow-up testing helps determine whether improvements have been sustained.
When should you discuss an HbA1c result with a healthcare professional?
An HbA1c result in the prediabetes or diabetes range deserves follow-up, even when a person feels well. Both conditions can develop without obvious symptoms, and early evaluation can help guide prevention or treatment.
A result at or above 6.5% should generally be confirmed when there are no clear symptoms or other findings that establish the diagnosis. A clinician may repeat HbA1c or use fasting plasma glucose or an oral glucose tolerance test, particularly when results are inconsistent.
People with a known diagnosis of diabetes should discuss results that are above their individualized target, especially if glucose readings have changed, symptoms have developed, or treatment is causing low blood sugar. A result that seems inconsistent with daily readings may warrant evaluation for anemia, altered red blood cell turnover, hemoglobin variants, or other sources of measurement bias.
Symptoms such as excessive thirst, frequent urination, unexplained weight loss, and blurred vision can occur with high blood glucose and should prompt medical evaluation. Vomiting, abdominal pain, deep or rapid breathing, confusion, or severe weakness in someone with possible diabetes can signal a medical emergency and require immediate care.
HbA1c is one of the most useful tools for understanding long-term blood sugar control, but it is not a complete picture of metabolic health. Interpreted alongside symptoms, other glucose tests, medical history, and individual treatment goals, it can help identify diabetes early, assess treatment effectiveness, and reduce the risk of long-term complications.